T
Transoma Medical
Transoma Medical, a private company based in Saint Paul
About Transoma Medical
Transoma Medical began its journey in 1984 as Data Sciences International (DSI), a pioneer in implantable wireless monitoring systems for biomedical research. Founded by Brian Brockaway, the company specialized in developing devices to monitor the effects of drugs on animals. Leveraging this expertise, Transoma spun off from DSI to adapt its technology for the human market, focusing on remote cardiac monitoring. Its key product, the Sleuth, was an implantable device designed to help doctors diagnose infrequent fainting spells. A promising player in the med-tech space, Transoma Medical attracted significant venture capital, raising $43.7 million in its later years. The company even filed for a $75 million initial public offering in 2007, a move aimed at commercializing the Sleuth device, which had received FDA clearance. However, due to deteriorating market conditions in 2008, the IPO was withdrawn. Despite having prominent investors, regulatory approval, and generating revenue, Transoma struggled to raise the additional capital needed to sustain its human applications division. In December 2009, the company announced it was shutting down its human-focused operations and ceasing business, a casualty of a challenging economic environment and a poor IPO market. While the parent company DSI continued its work in animal research, the Transoma Medical story serves as a stark reminder of the harsh realities of med-tech startups.
Source: Dealroom company dataNews
Open roles
Transoma Medical in the Saint Paul ecosystem
The Transoma Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Polaris Partners
Canaan
Affinity Capital Management
Series B and later1 investor entered at this stage
Cross Creek Advisors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Transoma Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Transoma Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


